Future research aims to further elucidate the interaction between BRCA1 and various environmental toxins. Advancements in genetic screening and personalized medicine hold promise for developing interventions that can mitigate the increased risks faced by individuals with BRCA1 mutations. Collaborative efforts in toxicogenomics will likely enhance our understanding of how genetic predispositions like BRCA1 mutations interact with environmental factors to influence cancer risk.
